AbComp: Measuring Abdominal Wall Compliance During Gynecologic Laparoscopic Surgery

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05012956
Collaborator
KU Leuven (Other)
40
2
24

Study Details

Study Description

Brief Summary

To measure abdominal wall compliance (AWC) during gynaecologic laparoscopy and assess its relation to the pelvic organ prolapse quantification (POP-Q) score of the same individual, and determine a relationship if present.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic sacrocolpopexy
  • Procedure: gynecologic laparoscopic surgery
N/A

Detailed Description

To characterize abdominal wall compliance (AWC), sterile reflective markers are attached to the abdominal wall by means of surgical tape, and the movement of these markers will be tracked with an optical tracker device. As during normal surgery, the intra-abdominal pressure (IAP) measured by the insufflator device will be recorded and stored on a secure computer with dedicated software. The pelvic organ quantification (POP-Q) score for each patient is determined pre-surgery as part of the standard of care. A biomechanical model will use reflective marker displacement (RMD) and IAP to calculate AWC. The POP-Q score will then be used to investigate a relation between AWC and degree of prolapse.

It is important to state that the trial does not intervene with the standard of care before- and during surgery. The used equipment is non-invasive and only requires about 5 minutes to be set up before the start of surgery. This set up comprises placing the optical tracker in the operating room such that it has a line of sight on the patient's abdomen and attaching the sterile markers to the abdominal wall. Therefore the trail does not add any additional risk to the surgery.

Each patient scheduled for gynecologic laparoscopy will be asked to participate in the study. If the patient wants to participate, she is presented the informed consent form (ICF). If both patient and clinician in charge sign the ICF, the patient is included in the study. The table below shows the patient specific information stored as part of the study.

Sample size calculation is based on a previous study (S61346), where we measured vaginal wall stiffness (the inverse of compliance) in patients with varying degrees of prolapse. 20 POP patients and 20 control group patients will be included.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Group 1: pelvic organ prolapse patients Group 2: patients assigned to gynecologic laparoscopic surgery, other than pelvic organ prolapse, at UZ Leuven.Group 1: pelvic organ prolapse patients Group 2: patients assigned to gynecologic laparoscopic surgery, other than pelvic organ prolapse, at UZ Leuven.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Measuring Abdominal Wall Compliance During Gynecologic Laparoscopic Surgery
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: POP group

Pelvic organ prolapse patients enrolled for sacrocolpopexy surgery at UZ Leuven.

Procedure: Laparoscopic sacrocolpopexy
During laparoscopic sacrocolpopexy, the anatomical position of the vaginal vault and cervix (if present) is restored by suturing a surgical mesh to the vaginal cuff or cervix and variable portions of the anterior and posterior vagina, while connecting the other end of the mesh to the anterior longitudinal ligament over the sacrum.

Active Comparator: Control group

Patients assigned to gynecologic laparoscopic surgery, other than sacrocolpopexy, at UZ Leuven.

Procedure: gynecologic laparoscopic surgery
Gynecologic laparoscopic surgery at UZ Leuven, other than sacrocolpopexy

Outcome Measures

Primary Outcome Measures

  1. Intra-abdominal pressure (IAC) [During surgery]

    Measured as part of the surgery by the insufflator device. [mmHg]

  2. Reflective marker displacement (RMD) [Druign surgery]

    Measured by an infrared camera and reflective markers attached to the abdominal wall. [mm]

Secondary Outcome Measures

  1. Pelvic organ quantification score [pre-surgery examination]

    Pelvic organ quantification (POP-Q) score, indicating the degree of pelvic organ prolapse (standardized method). The POP-Q score ranges from 0 (no prolapse) to IV (high prolapse). It is expected that a higher POP-Q score results in a higher abdominal wall compliance.

  2. Age [pre-srugery]

    Age of the patient

  3. BMI [pre-surgery]

    Body mass index

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients assigned to gynecologic laparoscopic surgery at UZ Leuven.
Exclusion Criteria:
  • Patients that are unable to give consent: In case of dementia or other cognitive disorders.

  • Patients that are unable to give consent: When they are unable to read and/or interpret the content of the informed consent form (ICF), which is written in Dutch.

  • Patients that had had an earlier abdominoplasty or abdominal wall mesh implantation, or other operations that directly affect the biomechanical properties of the abdominal wall.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universitaire Ziekenhuizen Leuven
  • KU Leuven

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
prof. dr. Jan Deprest, Prof. Dr., Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT05012956
Other Study ID Numbers:
  • S65329
First Posted:
Aug 19, 2021
Last Update Posted:
Sep 8, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 8, 2021